The results add to the growing evidence that the highly popular injection has broader health benefits for patients beyond treating Type 2 diabetes.
Source: https://www.cnbc.com/2024/03/05/novo-no ... ssion.html
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
